AIM ImmunoTech Inc. (AIM) - Stock Prices, Stock Peers & Analysis

Home
AIM

Company Name	AIM ImmunoTech Inc.
Symbol	AIM
Currency	USD
Price	0.449
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	21,853,010
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	0.29 - 0.84
Industry	Biotechnology
Sector	Healthcare
CEO	Mr. Thomas K. Equels Esq., J.D., M.S.
Website	https://www.aimimmuno.com

An error occurred while fetching data.

About AIM ImmunoTech Inc.

AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome (CFS). It